4.7 Article

shRNA-mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8

Journal

CELL DEATH & DISEASE
Volume 13, Issue 8, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41419-022-05140-w

Keywords

-

Categories

Funding

  1. National Natural Science Foundation of China [81972176]

Ask authors/readers for more resources

This study demonstrates the significance of KNTC1 in non-small-cell lung cancer by participating in the regulation of cell proliferation, migration, and invasion through the segregation of sister chromatids. The findings also suggest a positive association between KNTC1 depletion and PSMB8 expression. These findings indicate that KNTC1 may serve as a novel therapeutic target for non-small-cell lung cancer.
In view of the important roles played by Kinetochore proteins in mitosis, we believed that they may contribute to the development and progression of human cancers, which has been reported recently elsewhere. Kinetochore-associated 1 (KNTC1) participates in the segregation of sister chromatids during mitosis, the effects of which on non-small-cell lung cancer (NSCLC) remain unclear. Here, we sought to identify the biological significance of KNTC1 in NSCLC. KNTC1 protein expression in NSCLC tissues was investigated by immunohistochemistry. Lentivirus delivered short hairpin RNA (shRNA) was utilized to establish KNTC1 silence NSCLC cell lines. The effects of KNTC1 depletion on NSCLC cell proliferation, migration, apoptosis, and tumor formation were analyzed by MTT assay, wound-healing assay, transwell assay, flow cytometry assay, and in nude mouse models in vivo. After KNTC1 reduction, NSCLC cell viability, proliferation, migration, and invasion were restrained. A xenograft tumor model was also provided to demonstrate the inhibited tumorigenesis in NSCLC. In addition, the downstream mechanism analysis indicated that KNTC1 depletion was positively associated with PSMB8. The findings of the present study suggested that KNTC1 may have a pivotal role in mediating NSCLC progression and may act as a novel therapeutic target for NSCLC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available